Literature DB >> 11355047

24-Hour ambulatory blood pressure monitoring in primary care.

S F Gardner1, E F Schneider.   

Abstract

BACKGROUND: Both the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of Hypertension in Adults and the British Hypertension Society have made recommendations for the use of ambulatory blood pressure monitoring (ABPM) in select patient populations. This demonstration project explores the feasibility of a 24-hour ABPM service in assisting physicians with decisions regarding the implementation and modification of antihypertensive therapy.
METHODS: After physician referral, patients met with a pharmacist for evaluation of their blood pressure. The pharmacist obtained a medication profile and instructed each patient on the proper use of the monitor. Patients completed an activity diary while wearing the monitor. After analysis of the reports, the pharmacist forwarded recommendations and the 24-hour blood pressure data to the referring physician.
RESULTS: Sixty patients took part in the demonstration project. The primary reasons for referral included evaluation of suspected isolated office hypertension, drug resistance, blood pressure control in diabetic patients, and suspected drug-induced orthostatic hypotension. The referring physicians accepted 100% of the pharmacists' therapeutic recommendations. Unnecessary therapy was avoided in 12 of 40 of patients with suspected isolated office hypertension (30%), and more aggressive treatment was started in 6 of 7 of patients with type 2 diabetes (87.5%).
CONCLUSIONS: This project shows that a 24-hour ABPM consultation service can provide useful information for determining which patients have isolated office hypertension and in guiding drug regimen modification for patients with diabetes, suspected resistant hypertension, or drug-induced alterations in blood pressure.

Entities:  

Mesh:

Year:  2001        PMID: 11355047

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  6 in total

1.  Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting.

Authors:  Martin G Dawes; Gillian Bartlett; Andrew J Coats; Edmund Juszczak
Journal:  Ann Fam Med       Date:  2008 Sep-Oct       Impact factor: 5.166

2.  24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy.

Authors:  Joseph L Izzo; Steven G Chrysant; Dean J Kereiakes; Thomas Littlejohn Iii; Suzanne Oparil; Michael Melino; James Lee; Victor Fernandez; Reinilde Heyrman
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-10-28       Impact factor: 3.738

3.  Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement - is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I).

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-04-06

Review 4.  Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes?

Authors:  Gianfranco Parati; Grzegorz Bilo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

5.  Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey.

Authors:  Michael E Ernst; George R Bergus
Journal:  BMC Fam Pract       Date:  2003-10-08       Impact factor: 2.497

6.  Design and study protocol for a cluster randomized trial of a multi-faceted implementation strategy to increase the uptake of the USPSTF hypertension screening recommendations: the EMBRACE study.

Authors:  Nathalie Moise; Erica Phillips; Eileen Carter; Carmela Alcantara; Jacob Julian; Anusorn Thanataveerat; Joseph E Schwartz; Siqin Ye; Andrea Duran; Daichi Shimbo; Ian M Kronish
Journal:  Implement Sci       Date:  2020-08-08       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.